Quality of life of children with tuberous sclerosis complex
- PMID: 31122923
- DOI: 10.1136/archdischild-2018-316394
Quality of life of children with tuberous sclerosis complex
Abstract
Aim: Evaluation of impaired quality of life (QOL) of Malaysian children with tuberous sclerosis complex (TSC) and its possible risk factors.
Method: Cross-sectional study on 68 parents of Malaysian children aged 2-18 years with TSC. QOL was assessed using proxy-report Paediatric Quality of Life Inventory (PedsQL) V.4.0, and scores compared with those from a previous cohort of healthy children. Parents also completed questionnaires on child behaviour (child behaviour checklist (CBCL)) and parenting stress (parenting stress index-short form). Multiple regression analysis was used to determine sociodemographic, medical, parenting stress and behavioural factors that impacted on QOL.
Results: The mean proxy-report PedsQL V.4.0 total scale score, physical health summary score and psychosocial health summary score of the patients were 60.6 (SD 20.11), 65.9 (SD 28.05) and 57.8 (SD 19.48), respectively. Compared with healthy children, TSC patients had significantly lower mean PedsQL V.4.0 total scale, physical health and psychosocial health summary scores (mean difference (95% CI): 24 (18-29), 20 (12-27) and 26 (21-31) respectively). Lower total scale scores were associated with clinically significant CBCL internalising behaviour scores, age 8-18 years and Chinese ethnicity. Lower psychosocial health summary scale scores were associated with clinically significant CBCL internalising behaviour scores, Chinese ethnicity or >1 antiepileptic drug (AED).
Conclusion: Parents of children with TSC reported lower PedsQL V.4.0 QOL scores in all domains, with psychosocial health most affected. Older children, those with internalising behaviour problems, of Chinese ethnicity or on >1 AED was at higher risk of lower QOL. Clinicians need to be vigilant of QOL needs among children with TSC particularly with these additional risk factors.
Keywords: QOL; behaviour; psychosocial health; quality of life; tuberous sclerosis.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Quality of life in children with tuberous sclerosis complex: A pediatric cohort study.CNS Neurosci Ther. 2021 Mar;27(3):280-288. doi: 10.1111/cns.13473. Epub 2020 Nov 23. CNS Neurosci Ther. 2021. PMID: 33225634 Free PMC article.
-
Quality of life in patients with Tuberous Sclerosis Complex (TSC).Eur J Paediatr Neurol. 2019 Nov;23(6):801-807. doi: 10.1016/j.ejpn.2019.09.006. Epub 2019 Sep 13. Eur J Paediatr Neurol. 2019. PMID: 31543331
-
Health-related quality of life among Malaysian pediatric survivors of central nervous system tumor.Pediatr Hematol Oncol. 2023 Feb;40(1):26-39. doi: 10.1080/08880018.2022.2069895. Epub 2022 May 24. Pediatr Hematol Oncol. 2023. PMID: 35608384
-
Health utilities and quality of life in individuals with tuberous sclerosis complex (TSC) who experience epileptic seizures: A web-based survey.Epilepsy Behav. 2019 Mar;92:213-220. doi: 10.1016/j.yebeh.2018.11.021. Epub 2019 Jan 25. Epilepsy Behav. 2019. PMID: 30690322
-
Measurement of quality of life and attitudes towards illness in children and young people with chronic kidney disease.Qual Life Res. 2017 Sep;26(9):2409-2419. doi: 10.1007/s11136-017-1605-6. Epub 2017 May 27. Qual Life Res. 2017. PMID: 28551835 Review.
Cited by
-
Validation of the self-report quantified Tuberous Sclerosis Complex-Associated Neuropsyciatric Disorders Checklist (TAND-SQ).Orphanet J Rare Dis. 2025 Jun 13;20(1):304. doi: 10.1186/s13023-025-03642-2. Orphanet J Rare Dis. 2025. PMID: 40514711 Free PMC article.
-
Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex.Pharmacoecon Open. 2022 Jan;6(1):105-121. doi: 10.1007/s41669-021-00296-1. Epub 2021 Sep 15. Pharmacoecon Open. 2022. PMID: 34524653 Free PMC article.
-
Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis.Orphanet J Rare Dis. 2021 May 31;16(1):243. doi: 10.1186/s13023-021-01878-2. Orphanet J Rare Dis. 2021. PMID: 34059113 Free PMC article.
-
Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM.BMC Med. 2023 Aug 8;21(1):298. doi: 10.1186/s12916-023-03012-4. BMC Med. 2023. PMID: 37553648 Free PMC article.
-
Adverse Events of Everolimus in Patients with Tuberous Sclerosis Complex Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.Int J Med Sci. 2023 Sep 4;20(10):1358-1362. doi: 10.7150/ijms.88022. eCollection 2023. Int J Med Sci. 2023. PMID: 37786437 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical